Plasma and Red Blood Cell Choline in Aging: Rats, Monkeys and Man

  • E. F. Domino
  • B. Mathews
  • S. Tait
Part of the Advances in Behavioral Biology book series (ABBI, volume 30)


Plasma and red blood cell choline concentrations have been suggested as possible peripheral markers of brain cholinergie dysfunction in various human diseases such as major affective disorders, tardive dyskinesia, Tourette’s syndrome and senile dementia of the Alzheimer’s type (1, 2, 4–8, 10). The present study was initiated to explore these possible relationships in normal human volunteers and patients of similar age. The patients were diagnosed as having tardive dyskinesia or dementia of the Alzheimer’ s type. These patients were relatively old and their diets were difficult to control. Therefore, additional studies were done in rats and monkeys of various age groups where dietary factors could be held constant. The results obtained indicate that plasma and red blood cell choline levels do not correlate with brain dysfunction in either humans or monkeys. However, in these same species, with increasing age, plasma choline levels increase. Interestingly, increased plasma choline was not observed in aging rats.


Tardive Dyskinesia Nitrogen Phosphorus Choline Level Major Affective Disorder Plasma Choline 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barclay, L., Blass, J., Kopp, U. and Hanin, I. (1982): New Engl. J. Med. 307: 501.Google Scholar
  2. 2.
    Blass, J., Hanin, I., Barclay, L., Kopp, U. and Reding, M. (1983): This book.Google Scholar
  3. 3.
    Freeman, J., Choi, R. and Jenden, D. (1975): J. Neurochem. 24: 729–734.Google Scholar
  4. 4.
    Friedman, E., Sherman, K., Ferris, S., Reisberg, B., Bartus, R. and Schneck, M. (1981): New Engl. J. Med. 304: 1490–1491.Google Scholar
  5. 5.
    Greenwald, B., Edasery, J., Mohs, R., Horvath, T., Shah, N., Trigos, G. and Davis, K. (1983): Proc. Amer. Psychiat. Assoc., New Research Abstracts: NR 127.Google Scholar
  6. 6.
    Hanin, I., Merikangas, J., Merikangas, K. and Kopp, U. (1979): New Engl. J. Med. 301: 661–662.Google Scholar
  7. 7.
    Hanin, I., Kopp, U., Spiker, D., Neil, J., Shaw, D. and Kupfer, D. (1980): Psychiat. Res. 2: 345–355.Google Scholar
  8. 8.
    Hanin, I., Cohen, B., Kopp, U. and Lipinski, J. (1982): Psychopharm. Bull. 18: 186–190.Google Scholar
  9. 9.
    Jenden, D. and Hanin, I. (1974): In: Choline and Acetylcholine Handbook of Chemical Assay Methods (ed.) I. Hanin, Raven Press, New York, pp. 135–150.Google Scholar
  10. 10.
    Jope, R., Jenden, D., Ehrlich, B., Diamond, J. and Gosenfeld, L. (1980): Proc. Nat. Acad. Sci. USA 77: 6144–6146.Google Scholar
  11. 11.
    Marriott, J.G., Domino, E.F., Tait, S.K., Mathews, B.N., Fucek, F. and Abenson, J.S. (1981): Soc. Neurosci. Abst. 2: 950.Google Scholar
  12. 12.
    Domino, E.F., Marriott, J.G., Mathews, B.N., Domino, S.E. and Tait, S.K. (1982): Proceedings Abstracts: 13th CINP Congress, Jerusalem, Israel 1: 174.Google Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • E. F. Domino
    • 1
  • B. Mathews
    • 2
  • S. Tait
    • 2
  1. 1.Department of PharmacologyUniversity of MichiganAnn ArborUSA
  2. 2.Lafayette ClinicDetroitUSA

Personalised recommendations